Skip to search formSkip to main contentSkip to account menu

FN18-CRM9

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
BACKGROUND Tolerance is gaining momentum as an approach to reduce lifelong immunosuppressive therapy while improving transplant… 
2001
2001
Background. The T-cell receptor (TCR)/CD3 complex is the target of therapeutic strategies aimed at prolonging allograft survival… 
2000
2000
BACKGROUND In our previously described primate renal allograft model, T cell ablation leads to long-term graft survival. The role… 
1999
1999
BACKGROUND Immunosuppressive drugs that target T cells are useful for prolonging allograft survival. The anti-CD3 immunotoxin… 
Highly Cited
1998
Highly Cited
1998
BACKGROUND FN18-CRM9 is a CD3-specific immunotoxin that is capable of depleting CD3+ T cells. Pretreatment of rhesus monkeys with… 
Highly Cited
1997
Highly Cited
1997
BACKGROUND Renal allografts were performed in rhesus monkeys using FN18-CRM9, a potent immunotoxin capable of depleting T cells… 
1997
1997
We have previously developed a chemically conjugated anti-rhesus monkey CD3 immunotoxin FN18-CRM9 that can deplete in vivo T… 
1997
1997
FN18-CRM9 is an anti-rhesus anti-CD3 immunotoxin that can transiently deplete T cells to 1% of initial values in both the blood…